Stanislav Glezer
Director/Miembro de la Junta en Diabetes Foundation of New Jersey .
Fortuna: 207 678 $ al 30/04/2024
Cargos activos de Stanislav Glezer
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Diabetes Foundation of New Jersey | Director/Miembro de la Junta | 24/07/2019 | - |
Historial de carrera de Stanislav Glezer
Antiguos cargos conocidos de Stanislav Glezer.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INOGEN, INC. | Director Técnico/Científico/I+D | 21/06/2021 | 03/05/2024 |
| BECTON, DICKINSON AND COMPANY | Director Técnico/Científico/I+D | 01/09/2018 | 01/06/2021 |
| ADOCIA | Director Técnico/Científico/I+D | 26/07/2017 | 01/05/2018 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Director Técnico/Científico/I+D | 01/03/2016 | 01/03/2017 |
| Sanofi SA | Corporate Officer/Principal | - | - |
Formación de Stanislav Glezer.
| California Coast University | Masters Business Admin |
| Yevdokimov MSUMD | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
| Francia | 3 |
| Rusia | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| INOGEN, INC. | Health Technology |
| ADOCIA | Health Technology |
| Empresas privadas | 3 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
| Sanofi SA | Health Technology |
| Diabetes Foundation of New Jersey |
- Bolsa de valores
- Insiders
- Stanislav Glezer
- Experiencia
